Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Veritas Farms, Inc. (VFRM)
Fort Lauderdale, FL, US
Veritas Farms, Inc. focuses on growing, producing, marketing, and distributing hemp oils and extracts containing phytocannabinoids. The company’s products include capsules, gummies, tinctures, lotions, salves, cream, balm sticks, lip balms, and pet chews. It markets and sells its products under the Veritas Farms brand name, as well as through bulk, white label and private label custom formulations for distributors and retailers. The company was formerly known as SanSal Wellness Holdings, Inc. and changed its name to Veritas Farms, Inc. in February 2019. Veritas Farms, Inc. is based in Fort Lauderdale, Florida.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | -66.67% | -99.75% | -99.96% | -99.99% | -99.99% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Chemicals: +4.0%-65.5% Q3'23: +135.5% (vs Q3'22)
-
EPS growth Chemicals: +11.7%+23.5% ★ Q3'23: -16.2% (vs Q3'22)
-
FCF margin FCF growth · Chemicals: +41.7%-394.5% Q3'23: -253.9% (vs Q3'22)
-
EBIT margin Chemicals: +7.1%-438.2% Q3'23: -331.0% (vs Q3'22)
-
ROIC Chemicals: +3.4%-118.7% Q3'23: -76.4% (vs Q3'22)
-
Share dilution Chemicals: +0.0%-4.0% ★ Q3'23: +0.0% (vs Q3'22)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×-1.09× Q3'23: -1.34× (vs Q3'22)
Owner Earnings
Ownership Overview
Ownership breakdown not available.
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Cornelis F. Wit TTEE, Cornelis F. Wit Revocable Trust | 3.05M | 7.40% | 3.05M | — | 3.05M | — | OO | Netherlands | 2020-03-20 | ↗ |
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Thomas E. Vickers | Interim President, Chief Executive Officer, Chief Financial Officer, Principal Accounting Officer & Chairperson | 36.0K | male |
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for VFRM
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
